Neurotrauma Reports, published by MARY ANN LIEBERT, INC, stands at the forefront of disseminating pivotal research within the evolving field of neuroscience. With an emphasis on both cellular and molecular neuroscience and developmental neuroscience, this open access journal, initiated in 2020, aims to bridge gaps in knowledge concerning neurotrauma, a critical area impacting brain health and recovery. Although currently positioned in the lower quartiles as per the 2023 category rankings, the journal provides invaluable insights that foster academic dialogue and collaboration among researchers, professionals, and students alike. Through its commitment to open access, Neurotrauma Reports ensures that cutting-edge research is accessible to a diverse audience, enhancing the visibility of emerging studies and fostering innovation within the field. Readers can explore this journal to stay updated with the latest findings, methodologies, and reviews that are shaping our understanding of neurotrauma, ultimately contributing to improved treatments and outcomes.

NEUROSURGERY, published by Lippincott Williams & Wilkins, stands as a foremost journal in the field of clinical neurology and surgery, reflecting a commitment to advancing knowledge and practice through high-quality research and discourse. With an impact factor indicative of its scholarly significance and a remarkable Scopus ranking placing it in the Q1 category for both neurology and surgery, this journal provides a vital platform for clinicians, researchers, and students to explore cutting-edge developments and innovations. NEUROSURGERY publishes peer-reviewed articles that span the spectrum of neurosurgical practice, from basic science discoveries to clinical applications, fostering a collaborative exchange of ideas and methodologies. Since its inception in 1977, the journal has maintained a focus on delivering substantive research that informs practice and enhances patient care, making it an essential resource for professionals dedicated to the fields of neurology and surgery. The journal is based in India, and while it currently does not offer open access options, its rich archive from 1977 to 2024 ensures a comprehensive repository of knowledge for those engaged in this critical area of medicine.

Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.

Multiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.

Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.

Spinal Cord Series and Cases is an esteemed journal published by Springer Nature, dedicated to advancing the field of spinal cord research and neurology. With an ISSN of 2058-6124, this journal serves as a significant platform for disseminating high-quality studies, clinical reports, and innovative case analyses related to spinal cord conditions. Since its establishment in 2017, it has progressively gained recognition, having moved from Q4 to Q3 in both the neurology and clinical neurology categories as of 2023, indicating its rise in scholarly influence. The journal emphasizes open access to improve accessibility for researchers, clinicians, and students, ensuring the latest findings reach a global audience. Moreover, with a commitment to fostering interdisciplinary collaboration, Spinal Cord Series and Cases plays a crucial role in enhancing understanding and treatment of spinal cord disorders, making it an invaluable resource for professionals in medicine and allied fields.

NEUROMODULATION is a premier academic journal dedicated to advancing the fields of anesthesiology, pain medicine, and neurology. Published by Elsevier, this prestigious journal has consistently maintained a high impact factor, reflecting its relevance and influence in the medical community. With a commendable track record spanning from 1998 to 2024, NEUROMODULATION is classified in the Q1 quartile for both Anesthesiology and Pain Medicine and Medicine (miscellaneous), demonstrating its excellence among top-tier journals. Additionally, it ranks in the Q2 quartile for Neurology and Clinical Neurology, showcasing a broad appeal across multiple disciplines. The journal's substantial Scopus rankings—22nd out of 136 in Anesthesiology and Pain Medicine and 93rd out of 400 in Clinical Neurology—underscore its critical role in disseminating cutting-edge research and clinical findings. NEUROMODULATION endeavors to provide a robust platform for researchers, clinicians, and students to explore innovative therapeutic approaches and the complexities of neural modulation, ultimately contributing to improved patient outcomes and advancing the state of medical science.

BEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.

STROKE is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of neurology, cardiology, and specialized nursing. With an impressive impact factor and consistently ranked in the Q1 category across multiple disciplines—such as Advanced and Specialized Nursing, Cardiology, and Neurology—this journal serves as a crucial platform for researchers and healthcare professionals. It spans a rich historical context from 1970 to 2024, offering invaluable insights into stroke research and related cerebral vascular issues. The journal is committed to disseminating high-quality research that informs clinical practices and guides policy-making in public health. With a focus on empirical studies and clinical trials, STROKE stands as an essential resource for those invested in the complexities of neurological interventions and cardiovascular health. Ensure your access to this influential publication as it shapes the future of medical science and patient care.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.